Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 7/2019

15.05.2019 | Genetics

Ocular alterations, molecular findings, and three novel pathological mutations in a series of NF2 patients

verfasst von: Vanessa Waisberg, Luiz Oswaldo Carneiro Rodrigues, Márcio Bittar Nehemy, Luciana Bastos-Rodrigues, Débora Marques de Miranda

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate ophthalmological and molecular findings in eight patients with a clinical diagnosis of neurofibromatosis type 2 (NF2). New pathological mutations are described and variability in the ophthalmic phenotype and NF2 allelic heterogeneity are discussed.

Methods

Eye examination was performed in eight NF2 patients, and it included the measurement of the visual acuity, biomicroscopy, dilated fundus examination, color fundus photography, infrared photography, and spectral domain optical coherence tomography (SD-OCT). Molecular analysis was performed with whole-exome sequencing using DNA derived from peripheral blood mononuclear cells from each individual.

Results

Ophthalmological features were present in all patients, ranging from subtle retinal alterations identified only using SD-OCT to severe ocular damage present at birth. Six mutations were observed: two patients with stop codon mutation as shown on table 1 and result section, three patients with frameshift mutation as shown on table 1 and result section. Three novel mutations were found among them.

Conclusions

It is a descriptive study of a rare disease, with poor previous literature. Clinical and genetic data are shown, reviving the need to further studies to clarify the genotype-phenotype correlations in NF2.
Literatur
1.
Zurück zum Zitat NIH conference statement (1990) Neurofibromatosis 1 (von Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). Ann Intern Med 113:39–52CrossRef NIH conference statement (1990) Neurofibromatosis 1 (von Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). Ann Intern Med 113:39–52CrossRef
2.
Zurück zum Zitat Seizinger BR, Rouleau GA, Ozelius LJ et al (1987) Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 49:589–594CrossRefPubMed Seizinger BR, Rouleau GA, Ozelius LJ et al (1987) Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 49:589–594CrossRefPubMed
3.
Zurück zum Zitat Roleau G, Seizinger BR, Ozelius LG et al (1987) Genetic linkage analysis of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329:246–248CrossRef Roleau G, Seizinger BR, Ozelius LG et al (1987) Genetic linkage analysis of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329:246–248CrossRef
4.
Zurück zum Zitat Cooper J, Giancotti FG (2014) Molecular insights into NF2/Merlin tumor suppressor function. FEBS Lett 16:2743–2752CrossRef Cooper J, Giancotti FG (2014) Molecular insights into NF2/Merlin tumor suppressor function. FEBS Lett 16:2743–2752CrossRef
5.
Zurück zum Zitat Rodrigues LO, Batista PB, Goloni-Bertollo EM et al (2014) Neurofibromatosis part 1 – diagnosis and differential diagnosis. Arq Neuropsiquiatr 72:241–250CrossRefPubMed Rodrigues LO, Batista PB, Goloni-Bertollo EM et al (2014) Neurofibromatosis part 1 – diagnosis and differential diagnosis. Arq Neuropsiquiatr 72:241–250CrossRefPubMed
6.
Zurück zum Zitat Basser ME, Kuramoto L, Woods R et al (2005) The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2. J Med Genet 42:540–546CrossRef Basser ME, Kuramoto L, Woods R et al (2005) The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2. J Med Genet 42:540–546CrossRef
7.
Zurück zum Zitat Evans DG, Howard E, Giblin C et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet 152A:327–332CrossRefPubMed Evans DG, Howard E, Giblin C et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet 152A:327–332CrossRefPubMed
8.
Zurück zum Zitat Antinheimo J, Sankila R, Carpén O, Pukkala E, Sainio M, Jääskeläinen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71–76CrossRefPubMed Antinheimo J, Sankila R, Carpén O, Pukkala E, Sainio M, Jääskeläinen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71–76CrossRefPubMed
10.
Zurück zum Zitat Feucht M, Kluwe L, Mautner VF, Richard G (2008) Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2. Arch Ophthalmol 126:1376–1380CrossRefPubMed Feucht M, Kluwe L, Mautner VF, Richard G (2008) Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2. Arch Ophthalmol 126:1376–1380CrossRefPubMed
11.
Zurück zum Zitat Parry DM, MacCollin MM, Kaiser-Kupfer MI et al (1996) Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet 59:529–539PubMedPubMedCentral Parry DM, MacCollin MM, Kaiser-Kupfer MI et al (1996) Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet 59:529–539PubMedPubMedCentral
12.
Zurück zum Zitat Moon KH, Kim HT, Lee D, Rao MB, Levine EM, Lim DS, Kim JW (2018) Differential expression of NF2 in neuroepithelial compartments is necessary for mammalian eye development. Dev Cell 44:13–28CrossRefPubMed Moon KH, Kim HT, Lee D, Rao MB, Levine EM, Lim DS, Kim JW (2018) Differential expression of NF2 in neuroepithelial compartments is necessary for mammalian eye development. Dev Cell 44:13–28CrossRefPubMed
13.
Zurück zum Zitat Kaye LD, Rothner AD, Beauchamp GR, Meyers SM, Estes ML (1992) Ocular findings associated with neurofibromatosis type II. Ophthalmology 99:1424–1429CrossRefPubMed Kaye LD, Rothner AD, Beauchamp GR, Meyers SM, Estes ML (1992) Ocular findings associated with neurofibromatosis type II. Ophthalmology 99:1424–1429CrossRefPubMed
14.
Zurück zum Zitat Bosch MM, Boltshauser E, Harpes P, Landau K (2006) Ophthalmologic findings and a long-term course in patients with neurofibromatosis type 2. Am J Ophthalmol 141:1068–1077CrossRefPubMed Bosch MM, Boltshauser E, Harpes P, Landau K (2006) Ophthalmologic findings and a long-term course in patients with neurofibromatosis type 2. Am J Ophthalmol 141:1068–1077CrossRefPubMed
15.
Zurück zum Zitat Feucht M, Griffiths B, Niemüller I, Haase W, Richard G, Mautner VF (2008) Neurofibromatosis 2 leads to higher incidence of strabismological and neuro-ophthalmological disorders. Acta Ophthalmol 86:882–886CrossRefPubMed Feucht M, Griffiths B, Niemüller I, Haase W, Richard G, Mautner VF (2008) Neurofibromatosis 2 leads to higher incidence of strabismological and neuro-ophthalmological disorders. Acta Ophthalmol 86:882–886CrossRefPubMed
16.
Zurück zum Zitat Waisberg V, Rodrigues LO, Nehemy MB, Frassom M, De Miranda DM (2016) Spectral-domain optical coherence tomography findings in neurofibromatosis type 2. Inves Ophthalmol Vis Sci 57:OCT262–OCT267CrossRef Waisberg V, Rodrigues LO, Nehemy MB, Frassom M, De Miranda DM (2016) Spectral-domain optical coherence tomography findings in neurofibromatosis type 2. Inves Ophthalmol Vis Sci 57:OCT262–OCT267CrossRef
18.
Zurück zum Zitat Ahronowitz I, Xin W, Kiely R, Sims K, Maccollin M, Nunes FP (2007) Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat 28:1–12CrossRefPubMed Ahronowitz I, Xin W, Kiely R, Sims K, Maccollin M, Nunes FP (2007) Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat 28:1–12CrossRefPubMed
19.
Zurück zum Zitat Kluwe L, Mautner V, Heinrich B et al (2003) Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40:109–114CrossRefPubMedPubMedCentral Kluwe L, Mautner V, Heinrich B et al (2003) Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40:109–114CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Kluwe L, Mautner VF (1998) Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet 7:2051–2055CrossRefPubMed Kluwe L, Mautner VF (1998) Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet 7:2051–2055CrossRefPubMed
21.
Zurück zum Zitat Chan C, Koch CA, Kaiser-Kupfer MI et al (2002) Loss of heterozygosity for the NF gene in retinal and optic nerve lesions of patients with neurofibromatosis 2. J Pathol 198:14–20CrossRefPubMedPubMedCentral Chan C, Koch CA, Kaiser-Kupfer MI et al (2002) Loss of heterozygosity for the NF gene in retinal and optic nerve lesions of patients with neurofibromatosis 2. J Pathol 198:14–20CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Viola F, Villani E, Natacci F et al (2012) Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1. Ophthalmology 119:369–375CrossRefPubMed Viola F, Villani E, Natacci F et al (2012) Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1. Ophthalmology 119:369–375CrossRefPubMed
23.
Zurück zum Zitat Moramarco A, Giustini S, Nofroni I, Mallone F, Miraglia E, Lacovino C, Calvieri S, Lambiase A (2018) Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1. Graefes Arch Clin Exp Ophthalmol 256:307–311CrossRefPubMed Moramarco A, Giustini S, Nofroni I, Mallone F, Miraglia E, Lacovino C, Calvieri S, Lambiase A (2018) Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1. Graefes Arch Clin Exp Ophthalmol 256:307–311CrossRefPubMed
25.
Zurück zum Zitat Meyers SM, Gutman FA, Kaye LD, Rothner AD (1995) Retinal changes associated with neurofibromatosis 2. Trans Am Ophthalmol Soc 93:245–257PubMedPubMedCentral Meyers SM, Gutman FA, Kaye LD, Rothner AD (1995) Retinal changes associated with neurofibromatosis 2. Trans Am Ophthalmol Soc 93:245–257PubMedPubMedCentral
26.
Zurück zum Zitat Sisk RA, Berrocal AM, Schefler AC, Dubovy SR, Bauer MS (2010) Epirretinal membranes indicate a severe phenotype of neurofibromatosis type 2. Retina 30:51–58CrossRef Sisk RA, Berrocal AM, Schefler AC, Dubovy SR, Bauer MS (2010) Epirretinal membranes indicate a severe phenotype of neurofibromatosis type 2. Retina 30:51–58CrossRef
27.
Zurück zum Zitat McLaughlin ME, Pepin SM, MacCollin MM, Choopong P, Lessell S (2007) Ocular pathologic findings of neurofibromatosis type 2. Arch Ophthalmol 125:389–394CrossRefPubMed McLaughlin ME, Pepin SM, MacCollin MM, Choopong P, Lessell S (2007) Ocular pathologic findings of neurofibromatosis type 2. Arch Ophthalmol 125:389–394CrossRefPubMed
Metadaten
Titel
Ocular alterations, molecular findings, and three novel pathological mutations in a series of NF2 patients
verfasst von
Vanessa Waisberg
Luiz Oswaldo Carneiro Rodrigues
Márcio Bittar Nehemy
Luciana Bastos-Rodrigues
Débora Marques de Miranda
Publikationsdatum
15.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 7/2019
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-019-04348-5

Weitere Artikel der Ausgabe 7/2019

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2019 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.